Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
Stacey R Dillon,Cindy Sprecher,Angela Hammond,Janine Bilsborough,Maryland Rosenfeld-Franklin,Scott R Presnell,Harald S Haugen,Mark Maurer,Brandon Harder,Janet Johnston,Susan Bort,Sherri Mudri,Joseph L Kuijper,Tom Bukowski,Pamela Shea,Dennis L Dong,Maria Dasovich,Francis J Grant,Luann Lockwood,Steven D Levin,Cosette LeCiel,Kim Waggie,Heather Day,Stavros Topouzis,Janet Kramer,Rolf Kuestner,Zhi Chen,Don Foster,Julia Parrish-Novak,Jane A Gross
DOI: https://doi.org/10.1038/ni1084
IF: 30.5
2004-06-06
Nature Immunology
Abstract:T cell–derived cytokines are important in the development of an effective immune response, but when dysregulated they can promote disease. Here we identify a four-helix bundle cytokine we have called interleukin 31 (IL-31), which is preferentially produced by T helper type 2 cells. IL-31 signals through a receptor composed of IL-31 receptor A and oncostatin M receptor. Expression of IL-31 receptor A and oncostatin M receptor mRNA was induced in activated monocytes, whereas epithelial cells expressed both mRNAs constitutively. Transgenic mice overexpressing IL-31 developed severe pruritis, alopecia and skin lesions. Furthermore, IL-31 receptor expression was increased in diseased tissues derived from an animal model of airway hypersensitivity. These data indicate that IL-31 may be involved in promoting the dermatitis and epithelial responses that characterize allergic and non-allergic diseases.
immunology